3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9% -- Which Make for No-Brainer Buys in July

Core Viewpoint - The article highlights three ultra-high-yield dividend stocks that are positioned to provide significant returns for patient investors, emphasizing the historical performance of dividend stocks compared to non-payers and the current favorable market conditions for these investments [1][2][5]. Group 1: Dividend Stocks Performance - Dividend stocks have historically outperformed non-payers, with an average annual return of 9.2% compared to 4.31% from 1973 to 2024, while also exhibiting lower volatility [5]. - The S&P 500's current yield is 1.24%, making ultra-high-yield dividend stocks with yields averaging 9.02% particularly attractive [6]. Group 2: Annaly Capital Management - Annaly Capital Management offers a yield of 14.88%, having recently increased its quarterly payout and maintaining a double-digit yield over the past two decades [7]. - The company is entering a favorable growth environment due to a rate-easing cycle, which is expected to enhance its net interest margin [10]. - Annaly's investment portfolio, valued at $84.9 billion, is heavily weighted towards highly liquid agency assets, allowing for leverage and profit maximization [11]. Group 3: Pfizer - Pfizer has a current yield of 7.1%, which is projected to be sustainable based on management's growth forecasts [14]. - Despite a decline in COVID-19 related sales from over $56 billion to $11 billion between 2022 and 2024, Pfizer's overall net sales grew by more than 50% during the same period [16]. - The acquisition of Seagen for $43 billion is expected to add over $3 billion in annual sales and strengthen Pfizer's oncology pipeline [17]. - Pfizer's shares are trading at around 8 times forecast earnings, which is below the average forward P/E ratio of 10.2 over the past five years, indicating a potentially undervalued stock [18]. Group 4: The Campbell's Company - The Campbell's Company has a dividend yield of nearly 5.1%, which is at an all-time high [19]. - The stock is currently at a 16-year low due to weakened demand in the snack food category and the impact of steel tariffs, but these challenges are considered short-term [20]. - The company benefits from selling essential goods, leading to predictable cash flow regardless of economic conditions, making it a stable investment during volatility [21]. - Campbell's is investing $230 million through fiscal 2026 to improve operational efficiency and support brand value, alongside ongoing innovation [22]. - The stock is trading at around 10 times forecast earnings, representing a 31% discount to its average forward P/E ratio over the past five years [23].